These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6477534)

  • 21. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
    Hutson SM; Harper AE
    Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical basis of thiamin-responsive maple syrup urine disease.
    Chuang DT; Ku LS; Cox RP
    Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disturbance of cultured rat neuronal network activity depends on concentration and ratio of leucine and alpha-ketoisocaproate: implication for acute encephalopathy of maple syrup urine disease.
    Görtz P; Köller H; Schwahn B; Wendel U; Siebler M
    Pediatr Res; 2003 Feb; 53(2):320-4. PubMed ID: 12538793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.
    S Sonnet D; N O'Leary M; A Gutierrez M; M Nguyen S; Mateen S; Hsu Y; P Mitchell K; J Lopez A; Vockley J; K Kennedy B; Ramanathan A
    Sci Rep; 2016 Jul; 6():28775. PubMed ID: 27373929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
    Chuang DT; Ku LS; Cox RP
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of [1-(14)C] and [2-(14)C] leucine in cultured skin fibroblasts from patients with isovaleric acidemia. Characterization of metabolic defects.
    Tanaka K; Mandell R; Shih VE
    J Clin Invest; 1976 Jul; 58(1):164-72. PubMed ID: 932204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

  • 33. Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transfer.
    Mueller GM; McKenzie LR; Homanics GE; Watkins SC; Robbins PD; Paul HS
    Gene Ther; 1995 Sep; 2(7):461-8. PubMed ID: 7584124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
    Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
    J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.
    Schadewaldt P; Bodner A; Brösicke H; Hammen HW; Wendel U
    Pediatr Res; 1998 May; 43(5):592-600. PubMed ID: 9585004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrelationships of leucine and glutamate metabolism in cultured astrocytes.
    Yudkoff M; Daikhin Y; Lin ZP; Nissim I; Stern J; Pleasure D; Nissim I
    J Neurochem; 1994 Mar; 62(3):1192-202. PubMed ID: 7906717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

  • 38. Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease.
    Shigematsu Y; Kikuchi K; Momoi T; Sudo M; Kikawa Y; Nosaka K; Kuriyama M; Haruki S; Sanada K; Hamano N
    J Inherit Metab Dis; 1983; 6(4):183-9. PubMed ID: 6422161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maple syrup urine disease: two different forms within a single family.
    Frézal J; Amédée-Manesme O; Mitchell G; Heuertz S; Rey F; Rey J; Saudubray JM
    Hum Genet; 1985; 71(1):89-91. PubMed ID: 4029957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.